• Publications
  • Influence
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.
The prevalence of psychiatric disorders is greater than previously thought to be the case, and morbidity is more highly concentrated than previously recognized in roughly one sixth of the population who have a history of three or more comorbid disorders. Expand
The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures.
The design and development of the CIDI is described and the current field testing of a slightly reduced "core" version is described, allowing investigators reliably to assess mental disorders according to the most widely accepted nomenclatures in many different populations and cultures. Expand
Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.
The CIDI is a comprehensive and fully standardized diagnostic interview designed for assessing mental disorders according to the definitions of the Diagnostic Criteria for Research of ICD-10 and DSM-III-R and was found to be appropriate for use in different kinds of settings and countries. Expand
The World Health Organization Composite International Diagnostic Interview short‐form (CIDI‐SF)
Results are quite encouraging in suggesting that diagnostic classifications made in the full CIDI can be reproduced with excellent accuracy with the C IDI‐SF scales, however, independent verification of this reproduction accuracy is needed in a data set other than the one in which the CIDi‐SF was developed. Expand
The size and burden of mental disorders and other disorders of the brain in Europe 2010
The true size and burden of disorders of the brain in the EU was significantly underestimated in the past, and Concerted priority action is needed at all levels, including substantially increased funding for basic, clinical and public health research and policy decisions. Expand
Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
Estimates of 12‐month and lifetime prevalence and of lifetime morbid risk (LMR) of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM‐IV‐TR) anxiety andExpand
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Epidemiological data on a wide range of mental disorders from community studies conducted in European countries are presented to determine the availability and consistency of prevalence, disability and treatment findings for the EU, highlighting considerable future research needs for coordinated EU studies across all disorders and age groups. Expand
Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS)
Results confirm and extend results from other national studies using the same assessment instruments with regard to prevalence, co-morbidity and sociodemographic correlates, covering a broader range of DSM-IV disorders. Expand
The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys
Community epidemiological surveys using the World Health Organization Composite International Diagnostic Interview administered face‐to‐face were carried out in 10 countries in North America, Latin America, Europe, and Asia. Expand
The economic cost of brain disorders in Europe
This new report presents updated, more accurate, and comprehensive 2010 estimates of annual costs for brain disorders in Europe for 30 European countries. Expand